These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12809814)

  • 1. Elevated AST or ALT to nonalcoholic fatty liver disease: accurate predictor of disease prevalence?
    Yu AS; Keeffe EB
    Am J Gastroenterol; 2003 May; 98(5):955-6. PubMed ID: 12809814
    [No Abstract]   [Full Text] [Related]  

  • 2. The prevalence and etiology of elevated aminotransferase levels in the United States.
    Clark JM; Brancati FL; Diehl AM
    Am J Gastroenterol; 2003 May; 98(5):960-7. PubMed ID: 12809815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alanine aminotransferase/aspartate aminotransferase ratio reversal and prolonged prothrombin time: a specific indicator of hepatic cirrhosis.
    Siddiqi AI; Siddiqeh M; Mehmood A; Siddiqui AM
    J Ayub Med Coll Abbottabad; 2007; 19(3):22-4. PubMed ID: 18444585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AST/ALT ratio as an indicator of cirrhosis in patients with PBC.
    Nyblom H; Björnsson E; Simrén M; Aldenborg F; Almer S; Olsson R
    Liver Int; 2006 Sep; 26(7):840-5. PubMed ID: 16911467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002.
    Ioannou GN; Boyko EJ; Lee SP
    Am J Gastroenterol; 2006 Jan; 101(1):76-82. PubMed ID: 16405537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of AST/ALT ratio as fibrotic predictor in chronic hepatitis C.
    Park G; Jones DB; Katelaris P
    Am J Gastroenterol; 2005 Jul; 100(7):1623-4; author reply 1624. PubMed ID: 15984996
    [No Abstract]   [Full Text] [Related]  

  • 7. High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity.
    Papatheodoridis GV; Goulis J; Christodoulou D; Manolakopoulos S; Raptopoulou M; Andrioti E; Alexandropoulos N; Savvidou S; Papachristou A; Zervou E; Seferiadis K; Kousidou P; Vogiatzakis E; Tsianos E
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):281-7. PubMed ID: 17353691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Behavior of serum transaminases following physical stress in patients with liver diseases].
    Zwirner K
    Acta Hepatosplenol; 1970; 17(2):97-103. PubMed ID: 5524295
    [No Abstract]   [Full Text] [Related]  

  • 9. Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women.
    Kunde SS; Lazenby AJ; Clements RH; Abrams GA
    Hepatology; 2005 Sep; 42(3):650-6. PubMed ID: 16037946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are non-invasive tests accurate enough to predict hepatic fibrosis in non-alcoholic fatty liver disease (NAFLD)?
    Chavez-Tapia NC; Tiribelli C
    Gut; 2008 Oct; 57(10):1351-3. PubMed ID: 18791116
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasma enzyme activities in liver diseases during standardized physical exertion].
    Linneke P; Hoffmann H; Ehrke D; Lazarus P
    Z Gesamte Inn Med; 1973 Jan; 28(1):11-4. PubMed ID: 4694329
    [No Abstract]   [Full Text] [Related]  

  • 12. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
    Stránský J; Ryzlová M; Striteský J; Horák J
    Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.
    Kim CH; Park JY; Lee KU; Kim JH; Kim HK
    Diabetes Metab Res Rev; 2009 Jan; 25(1):64-9. PubMed ID: 19065605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
    Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AST:ALT ratios.
    Kawachi I; Robinson G; Stace N
    N Z Med J; 1990 Oct; 103(900):517-8. PubMed ID: 2288603
    [No Abstract]   [Full Text] [Related]  

  • 16. [Management of asymptomatic elevated serum aminotransferase levels, particularly in nonalcoholic steatohepatitis].
    Oldenburg B; Van Berge Henegouwen GP
    Ned Tijdschr Geneeskd; 1999 Mar; 143(10):506-9. PubMed ID: 10321258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On the value of galactose tolerance test in the enzymatic determination of blood galactose level].
    Mehnert H; Haslbeck M; Förster H
    Dtsch Med Wochenschr; 1968 Oct; 93(40):1899-905. PubMed ID: 5679122
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan.
    Chen CH; Huang MH; Yang JC; Nien CK; Yang CC; Yeh YH; Yueh SK
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1482-9. PubMed ID: 17716352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance.
    de Luis DA; Aller R; Izaola O; Sagrado MG; Conde R; Gonzalez JM
    Diabetes Res Clin Pract; 2008 Jan; 79(1):74-8. PubMed ID: 17766001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.